Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma

Surgery

Volumn 144, Issue 5, 2008, Pages 729-735

  Kobayashi, Takashi ^a   Teruya, Masanori ^a   Kishiki, Tomokazu ^a   Endo, Daisuke ^a   Takenaka, Yoshiharu ^a   Tanaka, Hozumi ^a   Miki, Kenji ^a   Kobayashi, Kaoru ^a   Morita, Koji ^a  

^a Showa General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CISPLATIN; FLUORODEOXYGLUCOSE; FLUOROURACIL;

ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BIOCHEMISTRY; CALCULATION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHYROTHORAX; CLINICAL ARTICLE; CONTINUOUS INFUSION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GLASGOW PROGNOSTIC SCORE; HEMATOMA; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOALBUMINEMIA; INFLAMMATION; LYMPH NODE; LYMPHATIC SYSTEM; MALE; OUTCOME ASSESSMENT; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; SCORING SYSTEM; SEPSIS; THORAX DISEASE; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; VEIN; VOCAL CORD PARALYSIS;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; NEOADJUVANT THERAPY; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 53949084890     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.08.015     Document Type: Article

References (31)

1. Lerut T., Coosemans W., De Leyn P., Van Raemdonck D., Deneffe G., and Decker G. Treatment of esophageal carcinoma. Chest 116 Suppl (1999) 463S-465S
2. Nygaard K., Hagen S., Hansen H.S., Hatlevoll R., Hultborn R., Jakobsen A., et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16 (1992) 1104-1109
3. Apinop C., Puttisak P., and Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41 (1994) 391-393
4. Le Prise E., Etienne P.L., Meunier B., Maddern G., Ben Hassel M., Gedouin D., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73 (1994) 1779-1784
5. Bosset J.F., Gignoux M., Triboulet J.P., Tiret E., Mantion G., Elias D., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
6. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
7. Burmeister B.H., Smithers B.M., Gebski V., Fitzgerald L., Simes R.J., Devitt P., et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6 (2005) 659-668
8. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., and Hennessy T.P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
9. Mariette C., Piessen G., and Triboulet J.P. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 8 (2007) 545-553
10. Mariette C., Piessen G., Lamblin A., Mirabel X., Adenis A., and Triboulet J.P. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg 93 (2006) 1077-1083
11. Gardner-Thorpe J., Hardwick R.H., and Dwerryhouse S.J. Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 94 (2007) 1059-1066
12. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
13. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
14. Crumley A.B., McMillan D.C., McKernan M., McDonald A.C., and Stuart R.C. Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 94 (2006) 637-641
15. McMillan D.C., Canna K., and McArdle C.S. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90 (2003) 215-219
16. McMillan D.C., Elahi M.M., Sattar N., Angerson W.J., Johnstone J., and McArdle C.S. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41 (2001) 64-69
17. Forrest L.M., McMillan D.C., McArdle C.S., Angerson W.J., and Dunlop D.J. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90 (2004) 1704-1706
18. Esophageal Disease Research Society. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. 9th ed. (1999), Kanehara, Tokyo
19. Roder J.D., Busch R., Stein H.J., Fink U., and Siewert J.R. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 81 (1994) 410-413
20. Siewert J.R., Bottcher K., Stein H.J., and Roder J.D. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228 (1998) 449-461
21. Canna K., McArdle P.A., McMillan D.C., McNicol A.M., Smith G.W., McKee R.F., et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92 (2005) 651-654
22. Hilmy M., Bartlett J.M., Underwood M.A., and McMillan D.C. The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer 92 (2005) 625-627
23. Jamieson N.B., Glen P., McMillan D.C., McKay C.J., Foulis A.K., Carter R., et al. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 92 (2005) 21-23
24. Crumley A.B., McMillan D.C., McKernan M., Going J.J., Shearer C.J., and Stuart R.C. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 94 (2006) 1568-1571
25. Scott H.R., McMillan D.C., Forrest L.M., Brown D.J., McArdle C.S., and Milroy R. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87 (2002) 264-267
26. McMillan D.C., Scott H.R., Watson W.S., Preston T., Milroy R., and McArdle C.S. Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31 (1998) 101-105
27. Bromwich E., McMillan D.C., Lamb G.W., Vasey P.A., and Aitchison M. The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer. Br J Cancer 91 (2004) 1236-1238
28. Tanigawa N., Amaya H., Matsumura M., and Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15 (1997) 826-832
29. Fondevila C., Metges J.P., Fuster J., Grau J.J., Palacin A., Castells A., et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 90 (2004) 206-215
30. Xavier P., Belo L., Beires J., Rebelo I., Martinez-de-Oliveira J., Lunet N., et al. Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 273 (2006) 227-231
31. Di Fiore F., Lecleire S., Pop D., Rigal O., Hamidou H., Paillot B., et al. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 102 (2007) 2557-2563